In this study, we analyzed the obstetric factors affecting total nucleated cells (TNC) content of cord blood units to establish the criteria for umbilical cord blood (UCB) donor selection in our geographic area. UCB was collected from normal uncomplicated pregnancies. In every case, following data were recorded: (1) gestation length; (2) type of delivery (cesarean or vaginal); and (3) newborn characteristics: weight and sex. For each sample, TNC content, percentage and number of CD34+ cells, and viability were analyzed. The results showed that TNC content increases with cord blood volume, gestational length and newborn weight. The mean blood volume and the mean TNC per unit were 42.37 ± 13.5 ml and 55.49 ± 19.4 × 10 7 , respectively. Stepwise regression analysis revealed a positive and significant correlation (r= 0.89) between these two variables. Meanwhile the CD34+ cell content remains unchanged in deliveries at 32-40 weeks of gestation. The mean CD34+ percentage obtained was 0.37 ± 0.06, and the total number of CD34+ cells was 4.827 ± 0.8204 × 10 4 / mL UCB. Concluding, the maternal and obstetric factors have a significant impact on UCB cell quantity and quality. The main criteria for UCB collection and storage resulted to be: a gestational age higher than 36-40 weeks and newborn weight > 3200g; gestation number ≤ 2 and placental weight > 700g can be added to the standard criteria to improve the bank efficiency. Our results have also become helpful in evaluating stored UCB units to establish the adequacy for clinical transplant utilization.
Introduction
Umbilical cord blood (UCB) has become an alternative to bone marrow and peripheral blood as source of progenitors and hematopoietic stem cells for transplant. The stem cells therapeutic spectrum includes several hematological malignances and other metabolic disorders [1] .
There are some benefits in the use of UCB: large-scale availability, relatively simple to harvest, lower risk for acute and chronic graft-versus-host disease due to the immunophenotype of UCB lymphocytes. Therefore, it has a certain ability to tolerate HLAmismatched transplants, which is higher than bone marrow or peripheral blood grafts. This fact increases significantly the donor circle for one recipient. The main limitation factor for the extensive use of UCB progenitor cells (CD34+) in transplant procedures is the limited number of cells that can be collected from each sample. The CD34 positive cells represent 1-3% of bone marrow cells, 0.1-0.4% of UCB cells, and respective 0.01-0.1% of peripheral blood cells [2] . In present, the current recommended number of total nucleated cells (TNC) for UCB transplantation is higher than 3.7 × 10 7 cells / kg of body weight [3] .
Based on successful transplantations, banks with UCB donations for future relatedand unrelated-donor allogeneic and autologous transplant are being established [4] . The economic consequences of all UCB units' storage will transform this process into something impractical, and soon impossible, in response to the limited available spaces in blood banks. Therefore, it may become important in the future to be able to distinguish deliveries that are likely to provide the most favorable cord blood collections for transplantations in order to optimize cost and storage space [5] . For this purpose, the sample's TNC content can bring important information. Some authors have reported that more than a half of the UCB units harvested for banking are discarded before cryopreservation due to low cell content.
In order to increase the efficiency of UCB units' collection process, a rigorous selection of donors was proposed based on a series of obstetric factors that can influence the cell number, preventing in this way the storing of ineffective blood units [6] [7] [8] . Thus, antenatal factors like alcohol consumption and cigarette smoking, maternal age, multiple gestations, ethnic origin, viral infections, obstetric factors (such as gestation, infant weight and sex), placental weight and mode of delivery (cesarean or vaginal) could have a significant impact on UCB cells quality and quantity.
For this study, we reviewed the reasons that can contribute to UCB donor's exclusion or the disposal of previously collected samples. These results could help redesign the criteria for donor's selection in our area and to further establish some general criteria for UCB collection and storage.
Statistical methods and Experimental Procedures

UCB collection
Cord blood collection was performed with ethics committee approval and maternal consent from 45 normal deliveries in the maternity ward of Dr. I. Cantacuzino Hospital (Bucharest). For vaginal deliveries, UCB was collected with placenta in utero. For cesarean section deliveries, UCB was collected following removal of the placenta (ex utero collection). After umbilical cord disinfection, cord blood was collected from the umbilical vein by gravity into 50 ml sterile plastic tube containing sodium citrate (5 mg/ml) as anticoagulant. Cord blood collection was stored at room temperature until processing.
Various conditions have been checked prior to UCB harvest: (1) absence of congenital diseases; (2) absence of surface Ag for B hepatitis (AgHBs), antibodies against HIV 1, 2 and anti-hepatitis C antibodies.
Obstetric data
For each delivery, the following data have been recorded: gestation length, number of previous gestations (parity), type of delivery (cesarean or spontaneous vaginal) and newborn characteristics (sex and weight).
Cord blood analysis
Each sample was processed and analyzed for TNC, percent of CD34+ cells, number and viability. Cell counts were performed with an automated hematology analyzer Abacus Junior (Diatron). CD34+ cells were quantified by flow cytometry using an Epics XL cytometer (Coulter Immunotech) after establishing the leukocyte gate on CD45+ cells. Ten thousand events were acquired and analyzed.
Statistical analysis
A univariate and multivariate analysis was performed in order to establish a model to explain the independent effect of analyzed factors (gestational length, maternal age, infant's sex and weight) on cord blood TNC and CD34+ cell content. Statistical tests were performed with a statistical software package (GraphPad InStat) using a multiple regression model. The results were analyzed with a 95% confidence interval by means of correlation coefficient r for each variable pair. Using p < 0.05 and r (0;1) were considered to be statistically significant.
Results
Factors affecting UCB volume and TNC content
Umbilical cord blood and obstetric data from 46 deliveries have been obtained and processed. Because no significant differences in TNC yield were associated with mode of delivery (cesarean or vaginal), data were merged. Predictor factors and significant outcomes are summarized in Table 1 . The mean blood volume collected was 42 ± 13.5 mL. The nucleate cell number average obtained from one UCB unit was 55.49 ± 19.4 × 10 7 . Regression analysis of the net volume and the total number of cells yielded showed a positive and significant correlation (r= 0.89) (Fig. 1) . Univariate analysis of data showed that when comparing the obstetric factors (Table 1), a higher gestational length and newborn's weight are positively associated to a higher TNC content ( Fig. 2 and 3) .
The main significant factors affecting total nucleated cell number were newborn's weight (P <0.001) and gestational length (P <0.001). Another factor that has a direct and significant influence on nucleated cell number is maternal age (P =0.04610). This factor's influence is inverse proportional with cell yield, as showed by negative coefficient obtained through statistical method analysis (-3.9 × 10 −1 ) ( Table 2) . Multivariate analysis of data using a multiple linear regression conducted to a series of equations, which consider whole of these parameters and can be extremely useful in estimating nuclear cell content of a UCB unit. Through this way, it is possible to establish the utility of a sample preventing the storage of an inadequate unit. 
CD34+ cell yields
The absolute number of CD34+ cells was determinate based on the flow cytometry results correlated with those obtained from automated hematology analyzer. CD34+ cells were determined as percentages of gate set on CD45+ side scatter cells and maintained throughout analysis (Fig. 4) .
The mean value of CD34+ cells obtained from 1 mL UCB was 4.827 ± 0.8204 × 10 4 . Regression analysis of the total CD34+ cells versus the UCB harvested showed a strong correlation (r = 0.7914, P < 0.001) (Fig. 5) . 
Discussion
Donor's selection is an important way to improve the safety and the quality of UCB units yielded for banking. In order to exclude the possibility of inherited diseases or infectious agents' transmission, some practical guidelines have been proposed. Most of them recommend different selection criteria such as: the absence of inherited diseases in family medical history and identification of some risk factors like HIV, HCV, HBV, syphilis and other infections pathogens. Additionally, various indicators such as the total nucleated cell number and CD34+ cell content are followed. Taking into account all these factors, some authors have estimated that approximate 39% of UCB collected units must be discarded [9, 10] . NETCORD standards for UCB harvesting, processing, testing, selection and storage, impose that UCB have to be yielded only from uncomplicated deliveries. They suggests also that the best results are obtained from cases in which the mother has his first or second baby, the gestational age is ≤ 40 weeks and the infant's weight is over 3600 g [11] . For those clinics in which UCB is harvested after placental expulsion, its weight can represent other valid obstetrical criteria for selecting efficient UCB units. Apparently there is a direct connection between newborn's weight, placental weight and UCB volume that can be collected [1, 11] . Solves et al showed that if placental weight is over 700 g, an adequate volume of cord blood can be collected for preservation. However, this can not represent valid criteria for centers that practice UCB harvest before newborn's expulsion. Instead, newborn's weight could be a more useful parameter.
In our study, 46 umbilical cord blood units have been collected to establish the adequacy and validity of criteria for our geographic area. The obtained results confirm a direct proportional relationship between total nucleated cell number and blood volume, gestation length and newborn's weight. Using the multiple regression models, we showed that these factors are dominant and significantly associated with increased TNC of UCB (p < 0,001). The relationship between obstetrical and neonatal factors resulted from our study has been summarized in two equations. These equations serve as a useful and quick method to determine and select adequate samples that may be considered for collection and storage based on the TNC number.
Comparing the obtained results with previous studies and guidelines, we demonstrate that less severe criteria can be applied. According to our results, a qualitative unit that corresponds with selection criteria can be obtained from babies over 3200g. Those units have an average >12 × 10 6 nucleated cells per mL, which means that if 100 mL UCB are collected, 120 × 10 7 cells can be obtained, enough to be useful for patients weighing 50 -60 kg of body weight.
Our results indicate also that the number of TNC grows directly proportional with gestation length and body weight and, in the mean time, the number of CD34+ is main- [4] . Many authors agree that gestational length must be taken into consideration prior to UCB collection [7, 8] . However, there is not a general agreement on the best gestational age for UCB collection. Most banks obtain units collected from full-term deliveries, defined as those with more than 36 weeks of gestation. Other banks collect cord blood units from gestations of more than 32 weeks [10] .
Comparing the results, CD34+ cells percentage appear to be higher on units yielded at lower gestational age (35-37 weeks) regarding those collected from 37-40 weeks old gestations, 0.42% versus 0.32%, but the total number of CD34+ cells remains almost constant around 3.56 × 10 6 / mL UCB. In our study, such analysis could not be performed due to the fact that only 7 from all 46 deliveries considered had a gestational age < 36 weeks, and the differences have not been significant. The mean percentage of CD34+ cells obtained by our team was 0.37 ± 0.06%, and the total number mean of CD34+ cells was 4.827 ± 0.8204 × 10 4 per mL UCB. Another factor that seems to influence the TNC number is the newborn's sex. Researches done by Aroviita P and Solves P showed that the nucleate cell number is significantly higher in units yielded from female babies than male ones. There are discrepancies in regards to the CD34+ number. Some authors claim that there are not significant differences between the sexes [1] , and others show that male infants had a higher CD34+ cell content then female, the difference in absolute concentration being around 5.3% [12, 13] .
Shlebak A et al suggest that the UCB's nucleated cell number is influenced by obstetric and genetic factors. In their study the authors showed the impact made by ethnic origin of the mother. Thus, non-Caucasian population has a CFU-GM (colony forming units of granulo-monocytes) yield lower and poor qualitatively comparative with Caucasian one, fact demonstrated by the authors through secondary CFU-GM colonies on replating in semisolid media [5] . Another study realized at a UCB bank in Valencia (Spain), shows that there are differences between criteria that can be applied for UCB collection based on infants characteristics from a specific geographic area [1] . This could explain the differences between the existing reports and conclude that stringent universal selection criteria can not be recommended.
Concluding, the maternal and obstetric factors have a significant impact on UCB cell quantity and quality. The main criteria for UCB collection and storage resulted to be: a gestational age higher than 36-40 weeks and newborn weight > 3200 g; gestation number ≤ 2 and placental weight > 700 g can be added to the standard criteria to improve the bank efficiency. Our results served as a useful method to determine and evaluate the adequacy of stored UCB units for clinical transplant utilization.
